Multiple Sclerosis and Related Disorders

Clinically isolated syndrome: the importance of early intervention 3:33
Clinically isolated syndrome: the importance of early intervention
Jacek Losy • 21 Oct 2020
Impact of COVID-19 on neurological disorders 1:32
Impact of COVID-19 on neurological disorders
Elena Moro • 22 Sep 2020
Therapeutic options in multiple sclerosis 4:08
Therapeutic options in multiple sclerosis
Celia Oreja-Guevara • 24 May 2020
Emerging research in pediatric MS 1:26
Emerging research in pediatric MS
Tanuja Chitnis • 24 May 2020
Menopause in multiple sclerosis patients 3:18
Menopause in multiple sclerosis patients
Celia Oreja-Guevara • 24 May 2020
Pediatric MS: where does research need to move? 1:08
Pediatric MS: where does research need to move?
Tanuja Chitnis • 24 May 2020
Diagnosis of multiple sclerosis: McDonald criteria 4:01
Diagnosis of multiple sclerosis: McDonald criteria
Celia Oreja-Guevara • 24 May 2020
Pediatric versus adult multiple sclerosis 1:24
Pediatric versus adult multiple sclerosis
Tanuja Chitnis • 24 May 2020
Multiple sclerosis: cladribine tablets real-world experience 3:09
Multiple sclerosis: cladribine tablets real-world experience
Celia Oreja-Guevara • 24 May 2020
TERIKIDS study: teriflunomide in pediatric patients with relapsing MS 2:12
TERIKIDS study: teriflunomide in pediatric patients with relapsing MS
Tanuja Chitnis • 24 May 2020
PREVENT study: eculizumab in patients with AQP4 immunoglobin G-positive NMOSD 3:38
PREVENT study: eculizumab in patients with AQP4 immunoglobin G-positive NMOSD
Celia Oreja-Guevara • 24 May 2020
MicroRNA biomarker panel for MS 1:18
MicroRNA biomarker panel for MS
Bárbara Guerra Leal • 21 May 2020
The content of VJNeurology is intended for healthcare professionals